COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2017

Dec 12, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2017-12-08

Reporting Person: Hirsch David (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-08	Common Stock	S	980350	$17.34	Disposed	2276222	Indirect
2017-12-08	Common Stock	S	19650	$17.34	Disposed	45620	Indirect

Footnotes

F1: Following the transactions reported herein, the reporting person has ceased to be the direct or indirect beneficial owner of more than 10% of any class of the Issuer's equity securities.

F2: Reflects securities held by Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Associates, L.P. ("LCA"). Longitude Capital Partners, LLC ("LCP") is the general partner of LVP and LCA. The reporting person is a member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. The reporting person disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of his pecuniary interest therein.